title: Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis.
abstract: Oral NaCl produces a greater natriuresis and diuresis than the intravenous infusion of the same amount of NaCl. Gastrin is the major gastrointestinal hormone taken up by renal proximal tubule (RPT) cells. We hypothesized that renal gastrin and dopamine receptors interact to synergistically increase sodium excretion, an impaired interaction of which may be involved in the pathogenesis of hypertension. In Wistar-Kyoto rats, infusion of gastrin induced natriuresis and diuresis, which was abrogated in the presence of a gastrin (cholecystokinin B receptor [CCKBR]; CI-988) or a D1-like receptor antagonist (SCH23390). Similarly, the natriuretic and diuretic effects of fenoldopam, a D1-like receptor agonist, were blocked by SCH23390, as well as by CI-988. However, the natriuretic effects of gastrin and fenoldopam were not observed in spontaneously hypertensive rats. The gastrin/D1-like receptor interaction was also confirmed in RPT cells. In RPT cells from Wistar-Kyoto but not spontaneously hypertensive rats, stimulation of either D1-like receptor or gastrin receptor inhibited Na(+)-K(+)-ATPase activity, an effect that was blocked in the presence of SCH23390 or CI-988. In RPT cells from Wistar-Kyoto and spontaneously hypertensive rats, CCKBR and D1 receptor coimmunoprecipitated, which was increased after stimulation of either D1 receptor or CCKBR in RPT cells from Wistar-Kyoto rats; stimulation of one receptor increased the RPT cell membrane expression of the other receptor, effects that were not observed in spontaneously hypertensive rats. These data suggest that there is a synergism between CCKBR and D1-like receptors to increase sodium excretion. An aberrant interaction between the renal CCK BR and D1-like receptors (eg, D1 receptor) may play a role in the pathogenesis of hypertension.
authors.affiliation: Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing 400042, China. chunyuzeng01@163.com.
authors.forename: Yue
authors.initials: Y
authors.lastname: Chen
authors.forename: Laureano D
authors.initials: LD
authors.lastname: Asico
authors.forename: Shuo
authors.initials: S
authors.lastname: Zheng
authors.forename: Van Anthony M
authors.initials: VA
authors.lastname: Villar
authors.forename: Duofen
authors.initials: D
authors.lastname: He
authors.forename: Lin
authors.initials: L
authors.lastname: Zhou
authors.forename: Chunyu
authors.initials: C
authors.lastname: Zeng
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Jose
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects*; D018491:Dopamine Agonists / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D018818:Fenoldopam / Q000494:pharmacology; D005755:Gastrins / Q000494:pharmacology*; D006727:Hormone Antagonists / Q000494:pharmacology; D006973:Hypertension / Q000503:physiopathology; D007211:Indoles / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D008536:Meglumine / Q000031:analogs & derivatives / Q000494:pharmacology; D009318:Natriuresis / Q000187:drug effects*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D017447:Receptors, Dopamine D1 / Q000819:agonists / Q000037:antagonists & inhibitors*
chemical_list: D001552:Benzazepines; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D005755:Gastrins; D006727:Hormone Antagonists; D007211:Indoles; D017447:Receptors, Dopamine D1; C534628:SCH 23390; C065599:PD 134308; D008536:Meglumine; D018818:Fenoldopam
keywords: hypertension; kidney; kidney tubules, proximal; receptor, cholecystokinin B; receptors, dopamine D1
references.citation: Fundam Clin Pharmacol. 1998;12(3):256-62
references.pmid: 9646057
references.citation: Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G51-7
references.pmid: 11123197
references.citation: J Clin Invest. 2003 Oct;112(8):1244-54
references.pmid: 14561709
references.citation: Nephron. 2002 Oct;92(2):373-8
references.pmid: 12218317
references.citation: Hypertension. 2008 Apr;51(4):811-6
references.pmid: 18332286
references.citation: Hypertension. 2012 Jan;59(1):14-21
references.pmid: 22068865
references.citation: Hypertension. 2012 Aug;60(2):396-403
references.pmid: 22710646
references.citation: Am J Physiol. 1998 Oct;275(4):R986-94
references.pmid: 9756526
references.citation: Clin Exp Hypertens A. 1992;14(4):615-28
references.pmid: 1352742
references.citation: Hypertension. 2009 Mar;53(3):564-70
references.pmid: 19139376
references.citation: J Clin Invest. 2008 Jun;118(6):2180-9
references.pmid: 18464932
references.citation: Kidney Int. 2000 Sep;58(3):995-1003
references.pmid: 10972664
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3872-7
references.pmid: 11904438
references.citation: Am J Physiol. 1999 Nov;277(5):G960-6
references.pmid: 10564101
references.citation: Hypertension. 2012 May;59(5):899-905
references.pmid: 22431584
references.citation: Hypertension. 2012 Nov;60(5):1359-66
references.pmid: 22987918
references.citation: Clin Exp Hypertens. 1996 Oct;18(7):963-74
references.pmid: 8886479
references.citation: Nucl Med Biol. 2007 Aug;34(6):633-41
references.pmid: 17707803
references.citation: Br J Pharmacol. 2005 Apr;144(7):933-9
references.pmid: 15711596
references.citation: Am J Physiol Cell Physiol. 2011 Mar;300(3):C425-34
references.pmid: 21160026
references.citation: Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2761-8
references.pmid: 18441198
references.citation: Am J Physiol Renal Physiol. 2010 Jul;299(1):F49-54
references.pmid: 20462969
references.citation: Kidney Int. 2006 Sep;70(6):1072-9
references.pmid: 16850019
references.citation: Am J Physiol Renal Physiol. 2010 May;298(5):F1205-13
references.pmid: 20181665
references.citation: Diabetes. 2012 Apr;61(4):897-907
references.pmid: 22357963
references.citation: Curr Opin Nephrol Hypertens. 2012 Jan;21(1):61-5
references.pmid: 22123211
references.citation: Am J Physiol Renal Physiol. 2007 Sep;293(3):F877-84
references.pmid: 17567939
references.citation: J Physiol. 1988 Mar;397:527-38
references.pmid: 3411518
references.citation: Life Sci. 1987 Apr 13;40(15):1499-506
references.pmid: 2951574
references.citation: Am J Physiol. 1990 Jul;259(1 Pt 2):F138-46
references.pmid: 2142857
references.citation: Circ Res. 1978 Jul;43(1):19-23
references.pmid: 657455
references.citation: Curr Hypertens Rep. 2008 Aug;10(4):268-75
references.pmid: 18625155
references.citation: Endocrinology. 2001 Jul;142(7):3087-97
references.pmid: 11416031
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H551-69
references.pmid: 18083900
references.citation: Acta Physiol Scand. 2002 Jun;175(2):165-71
references.pmid: 12028137
references.citation: J Am Soc Nephrol. 2012 Mar;23(3):421-8
references.pmid: 22193384
references.citation: Am J Physiol. 1998 Apr;274(4 Pt 1):G607-13
references.pmid: 9575840
references.citation: Cell Physiol Biochem. 2004;14(1-2):91-100
references.pmid: 14976410
references.citation: J Ren Nutr. 2009 Jan;19(1):57-60
references.pmid: 19121772
references.citation: Am J Physiol Regul Integr Comp Physiol. 2001 Oct;281(4):R1071-8
references.pmid: 11557612
references.citation: Curr Hypertens Rep. 2011 Feb;13(1):55-66
references.pmid: 21058046
references.citation: Br J Pharmacol. 1999 May;127(2):530-6
references.pmid: 10385255
references.citation: Hypertension. 1997 Jan;29(1 Pt 1):115-22
references.pmid: 9039090
references.citation: Am J Clin Nutr. 1997 Feb;65(2 Suppl):626S-642S
references.pmid: 9022559
references.citation: Annu Rev Physiol. 2008;70:379-403
references.pmid: 17988205
references.citation: Curr Top Med Chem. 2007;7(12):1154-65
references.pmid: 17584137
references.citation: Eur J Clin Invest. 1998 Jul;28(7):592-601
references.pmid: 9726041
references.citation: Kidney Int. 2002 Sep;62(3):790-8
references.pmid: 12164861
references.citation: Hypertension. 1998 Dec;32(6):1049-53
references.pmid: 9856972